Stock Scorecard



Stock Summary for Precision Biosciences Inc (DTIL) - $13.56 as of 3/28/2024 9:27:42 PM EST

Total Score

10 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for DTIL

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for DTIL

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for DTIL

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for DTIL

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for DTIL

Precision BioSciences ( DTIL ) Reports Q4 Loss, Lags Revenue Estimates 3/27/2024 12:10:00 PM
Stoke Therapeutics, Inc. ( STOK ) Reports Q4 Loss, Lags Revenue Estimates 3/25/2024 9:10:00 PM
Liquidia Technologies, Inc. ( LQDA ) Reports Q4 Loss, Lags Revenue Estimates 3/13/2024 11:10:00 AM
Avidity Biosciences, Inc. ( RNA ) Reports Q4 Loss, Misses Revenue Estimates 2/28/2024 10:20:00 PM
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results 2/28/2024 12:00:00 PM
Strength Seen in Precision BioSciences ( DTIL ) : Can Its 20.4% Jump Turn into More Strength? 2/27/2024 9:25:00 AM
Genome Editing Market Size & Share to Surpass USD 17.5 billion by 2031, Exhibiting a CAGR of 13.9% | States Transparency Market Research, Inc. 2/12/2024 2:33:00 PM
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs 1/23/2024 1:05:00 PM
Why Is Multiple Sclerosis Focused TG Therapeutics ( TGTX ) Stock Trading Higher Today? - TG Therapeutics ( NASDAQ:TGTX ) 1/10/2024 1:48:00 PM
Why Aehr Test Systems Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket - Aehr Test Systems ( NASDAQ:AEHR ) , AERWINS Technologies ( NASDAQ:AWIN ) 1/10/2024 1:02:00 PM

Financial Details for DTIL

Company Overview

Ticker DTIL
Company Name Precision Biosciences Inc
Country USA
Description Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. The company is headquartered in Durham, North Carolina.
Sector Name LIFE SCIENCES
Industry Name BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Most Recent Quarter 9/30/2023
Next Earnings Date 3/27/2024

Stock Price History

Last Day Price 13.56
Last Day Price Updated 3/28/2024 9:27:42 PM EST
Last Day Volume 191,191
Average Daily Volume 200,031
52-Week High 28.44
52-Week Low 8.25
Last Price to 52 Week Low 64.36%

Valuation Measures

Trailing PE N/A
Industry PE 66.35
Sector PE 60.76
5-Year Average PE -126.27
Free Cash Flow Ratio 0.73
Industry Free Cash Flow Ratio 17.10
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 2.88
Total Cash Per Share 18.62
Book Value Per Share Most Recent Quarter 7.54
Price to Book Ratio 2.88
Industry Price to Book Ratio 7.21
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 1.60
Industry Price to Sales Ratio Twelve Trailing Months 32.37
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 6,564,000
Market Capitalization 89,007,840
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -264.80%
Reported EPS 12 Trailing Months -25.76
Reported EPS Past Year -0.40
Reported EPS Prior Year -1.40
Net Income Twelve Trailing Months -73,518,000
Net Income Past Year -111,637,000
Net Income Prior Year -30,602,000
Quarterly Revenue Growth YOY 78.20%
5-Year Revenue Growth -71.84%

Balance Sheet

Total Cash Most Recent Quarter 122,231,000
Total Cash Past Year 189,576,000
Total Cash Prior Year 143,663,000
Net Cash Position Most Recent Quarter 99,866,000
Net Cash Position Past Year 167,353,000
Long Term Debt Past Year 22,223,000
Long Term Debt Prior Year 2,478,000
Total Debt Most Recent Quarter 22,365,000
Equity to Debt Ratio Past Year 0.73
Equity to Debt Ratio Most Recent Quarter 0.57
Total Stockholder Equity Past Year 60,433,000
Total Stockholder Equity Prior Year 91,168,000
Total Stockholder Equity Most Recent Quarter 29,063,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.21
MACD Signal -0.14
20-Day Bollinger Lower Band 10.33
20-Day Bollinger Middle Band 11.85
20-Day Bollinger Upper Band 13.38
Beta 1.55
RSI 49.14
50-Day SMA 15.18
200-Day SMA 142.71

System

Modified 3/27/2024 11:11:54 PM EST